Veeva Systems Inc. (VEEV) is a publicly traded Healthcare sector company. As of May 20, 2026, VEEV trades at $164.59 with a market cap of $26.74B and a P/E ratio of 29.37. VEEV moved +1.09% today. Year to date, VEEV is -25.47%; over the trailing twelve months it is -31.49%. Its 52-week range spans $148.05 to $310.50. Analyst consensus is buy with an average price target of $263.52. Rallies surfaces VEEV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Veeva to Host 100+ AI Sessions at Boston Summit with Top Biopharma: Veeva Systems will host its Commercial Summit on May 19-20 in Boston featuring over 100 sessions on Commercial Cloud, Data Cloud, and agentic commercial powered by industry-specific AI. Biopharma leaders from Genentech, GSK, Merck, Novo Nordisk and others will present AI-driven CRM innovations and data strategies to enhance sales, marketing, and medical engagement.
| Metric | Value |
|---|---|
| Price | $164.59 |
| Market Cap | $26.74B |
| P/E Ratio | 29.37 |
| EPS | $5.55 |
| Dividend Yield | 0.00% |
| 52-Week High | $310.50 |
| 52-Week Low | $148.05 |
| Volume | 1.51M |
| Avg Volume | 0 |
| Revenue (TTM) | $3.20B |
| Net Income | $908.91M |
| Gross Margin | 75.53% |
22 analysts cover VEEV: 0 strong buy, 14 buy, 7 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $263.52.